investor.megawecare.com

Mega Lifesciences

Investor Relations Delivering value to our shareholders with utmost transparency and timely information. Financial Highlights in 1Q26 Overall Operating Revenue THB mn (grew by 14.4% YoY) Gross Profit THB mn representing 52.3% of operating revenue SG&A Expenses THB mn representing 30.8% of operating revenue EBITDA THB mn (grew by 41.8% YoY) Reported net profit THB mn (grew by 34.4% YoY) Adjusted net profit THB mn (grew by 16.2% YoY) Explore More Upcoming Events IR Calendar SET Announcements View All View All Latest Documents Resource Center Keep Yourself Up To Date with all the latest announcements from the company. Subscribe IR Contact Mr. Manoj Gurbuxan